These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [In vitro activity of 9 antibiotics and 3 beta-lactamase inhibitors against 107 clinical isolates of Acinetobacter baumanii]. Echeverría MJ, López de Goicoechea MJ, Ayarza R, Vecino Y, Lazpita MA, Ibarretxebea AB, Barbier A, Cruz González M, Martínez de la Fuente P. Enferm Infecc Microbiol Clin; 1997; 15(6):319-22. PubMed ID: 9376404 [Abstract] [Full Text] [Related]
3. [In vitro activity of beta-lactam agents and beta-lactamase inhibitors in clinical isolates of Acinetobacter baumannii]. López-Hernández S, Alarcón T, Delgado T, de Las Cuevas MC, López-Brea M. Rev Esp Quimioter; 1999 Jun; 12(2):140-3. PubMed ID: 10562675 [Abstract] [Full Text] [Related]
5. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics]. Alişkan H, Colakoğlu S, Turunç T, Demiroğlu YZ, Erdoğan F, Akin S, Arslan H. Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430 [Abstract] [Full Text] [Related]
6. [Antibiotic resistance of Acinetobacter baumannii isolates: data from Ibni Sina Hospital for the year 2002]. Akan OA. Mikrobiyol Bul; 2003 Oct; 37(4):241-6. PubMed ID: 14748260 [Abstract] [Full Text] [Related]
7. [Susceptibility pattern of Acinetobacter baumannii clinical isolates in Madrid vs. Hong Kong]. García-Peñuela E, Aznar E, Alarcón T, López-Brea M. Rev Esp Quimioter; 2006 Mar; 19(1):45-50. PubMed ID: 16688291 [Abstract] [Full Text] [Related]
8. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin. Dueñas Díez AI, Bratos Pérez MA, Eiros Bouza JM, Almaraz Gómez A, Gutiérrez Rodríguez P, Miguel Gómez MA, Orduña Domingo A, Rodríguez-Torres A. Int J Antimicrob Agents; 2004 May; 23(5):487-93. PubMed ID: 15120728 [Abstract] [Full Text] [Related]
15. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam. Sader HS, Tosin I, Sejas L, Miranda E. Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842 [Abstract] [Full Text] [Related]
17. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro]. Zhao C, Xie W, Zhang W, Ye Z, Wu H. Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663 [Abstract] [Full Text] [Related]
18. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU. Sheng WH, Wang JT, Li SY, Lin YC, Cheng A, Chen YC, Chang SC. Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048 [Abstract] [Full Text] [Related]
19. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria. Punpanich W, Tantichattanon W, Wongwatcharapaiboon S, Treeratweeraphong V. J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989 [Abstract] [Full Text] [Related]